I agree that this site is using cookies. You can find further informations here.
X
Czuczman, Natalie M.
~ 0  results:
Search for persons X
?
1

Systematic Review and Meta-Analysis: Prevalence of Neurodev..:

Lau, Stuart C. ; Czuczman, Natalie M. ; Dennett, Liz..
JAACAP Open.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

The novel proteasome inhibitor carfilzomib induces cell cyc..:

Gu, Juan J. ; Hernandez‐Ilizaliturri, Francisco J. ; Kaufman, Gregory P....
British Journal of Haematology.  162 (2013)  5 - p. 657-669 , 2013
Link: https://doi.org/10.1111/..
 
?
3

Pevonedistat, a NEDD8-activating enzyme inhibitor, is activ..:

Czuczman, Natalie M ; Barth, Matthew J ; Gu, Juan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778163/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
4

The novel proteasome inhibitor carfilzomib (CFZ) induces ce..:

Gu, Juan J ; Hernandez-Ilizaliturri, Francisco J ; Kaufman, Gregory P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
5

MLN2238, a proteasome inhibitor, induces caspase-dependent ..:

Gu, Juan J ; Hernandez-Ilizaliturri, Francisco J ; Mavis, Cory...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685502/.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
6

72 Prevalence of Neurodevelopmental Disorder among Indigeno..:

Lau, Stuart ; Czuczman, Natalie ; Dennett, Liz..
Paediatrics & Child Health.  27 (2022)  Supplement_3 - p. e34-e34 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Novel induced-mesenchymal stem cells (i-MSCS) attenuate sev..:

Hashimoto, K. ; Bazhanov, N. ; Enkhbaatar, P....
Cytotherapy.  23 (2021)  5 - p. S33 , 2021
Link: https://doi.org/10.1016/..
 
?
8

A comprehensive review of lenalidomide therapy for B-cell n..:

Witzig, T.E. ; Nowakowski, G.S. ; Habermann, T.M....
Annals of Oncology.  26 (2015)  8 - p. 1667-1677 , 2015
Link: https://doi.org/10.1093/..
 
?
9

Long-term follow-up of lenalidomide in relapsed/refractory ..:

Zinzani, P.L. ; Vose, J.M. ; Czuczman, M.S....
Annals of Oncology.  24 (2013)  11 - p. 2892-2897 , 2013
Link: https://doi.org/10.1093/..
 
?
10

An international phase II trial of single-agent lenalidomid..:

Witzig, T.E. ; Vose, J.M. ; Zinzani, P.L....
Annals of Oncology.  22 (2011)  7 - p. 1622-1627 , 2011
Link: https://doi.org/10.1093/..
 
?
11

Radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin) ..:

Schilder, R.J. ; Molina, A. ; Gordon, L.I....
International Journal of Radiation Oncology*Biology*Physics.  60 (2004)  1 - p. S545 , 2004
Link: https://doi.org/10.1016/..
 
?
12

Epitopes immunologically related to glycophorin a on human ..:

Barsoum, A. L. ; Czuczman, M. S. ; Bhavanandan, V. P..
International Journal of Cancer.  34 (1984)  6 - p. 789-795 , 1984
Link: https://doi.org/10.1002/..
 
?
13

Erector spinae plane block vs. peri‐articular injection for..:

Shanthanna, H. ; Czuczman, M. ; Moisiuk, P....
Anaesthesia.  77 (2021)  3 - p. 301-310 , 2021
Link: https://doi.org/10.1111/..
 
?
14

POST HOC ANALYSES OF PATIENTS WITH RELAPSED/REFRACTORY MARG..:

Thieblemont, C. ; Leonard, J. ; Trneny, M....
Hematological Oncology.  37 (2019)  S2 - p. 226-227 , 2019
Link: https://doi.org/10.1002/..
 
?
15

ROBUST: First report of phase III randomized study of lenal..:

Vitolo, U. ; Witzig, T.E. ; Gascoyne, R.D....
Hematological Oncology.  37 (2019)  S2 - p. 36-37 , 2019
Link: https://doi.org/10.1002/..
 
1-15